LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Recent Advances in Small Copper Sulfide Nanoparticles for Molecular Imaging and Tumor Therapy.

Photo from wikipedia

Small copper sulfide nanoparticles (s-Cu2-xS NPs, 0 < x < 1) with a core size of less than 5.5 nm have unique physicochemical characteristics and pharmacokinetic properties and have attracted… Click to show full abstract

Small copper sulfide nanoparticles (s-Cu2-xS NPs, 0 < x < 1) with a core size of less than 5.5 nm have unique physicochemical characteristics and pharmacokinetic properties and have attracted substantial attention from researchers in the field of biomedicine in recent years. After exposure to near-infrared (NIR) light, s-Cu2-xS NPs can rapidly convert light energy into heat for photoacoustic imaging (PAI) and photothermal therapy (PTT). In addition, the potential for magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging, along with the low toxicity and low cost, makes s-Cu2-xS NPs a promising multifunctional diagnostic reagent. This Review outlines recent advances in s-Cu2-xS NPs for molecular imaging and tumor therapy and discusses the challenges associated with successful clinical translation.

Keywords: small copper; copper sulfide; sulfide nanoparticles; cu2 nps; recent advances; therapy

Journal Title: Molecular pharmaceutics
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.